Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All
Firm with Earth City unit is settling suits over drugs tied to suicides - St. Louis Post-Dispatch
Firm with Earth City unit is settling suits over drugs tied to suicidesSt. Louis Post-DispatchAccording to federal regulators, Forest waged an aggressive campaign from 1999 through at least 2005 to promote the use of Celexa and Lexapro in children ...Looking at the Trees in Forest LaboratoriesSeeking AlphaForest Laboratories settling host of lawsuitsMissourinet.comall 5 news articles��
Shire To Talk With Regulators For Additional Studies Of Vyvanse - Wall Street Journal
Shire To Talk With Regulators For Additional Studies Of VyvanseWall Street JournalA mid-stage trial of Vyvanse in patients with residual depression following treatment with Lexapro, an antidepressant sold by Forest Laboratories Inc. (FRX) ...Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R ...PR Newswire (press release)Shire Reports Phase 2 Signal Finding Study Results Of Vyvanse CapsulesStock Markets Reviewall 23 news articles��
Kentucky Gets Part of Lexapro Settlement - Lawyers and Settlements
Minyanville.comKentucky Gets Part of Lexapro SettlementLawyers and Settlements... Inc., which was accused of providing misleading information about Lexapro birth defects and other potential adverse reactions to some of its drugs, ...Forest Laboratories' Looming Patent ProblemsMinyanville.comall 2 news articles��
Forest quarterly profit, drug sales, rise - Reuters
Proactive Investors USA & CanadaForest quarterly profit, drug sales, riseReutersSales of antidepressant Lexapro were roughly flat at $569.3 million, while sales of Namenda rose 12.7 percent to $310.1 million and sales of Bystolic rose ...Forest Labs 2Q Net Up 53% Amid 2009 Charges; EPS View RaisedWall Street JournalForest Laboratories 2Q profit grows 53 percentBusinessWeekForest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per ...MarketWatch (press release)Proactive Investors USA & Canada�-RTT Newsall 50 news articles��
Last updated on: Jan 24, 2007
Lexapro is in a class of medicines called selective serotonin reuptake inhibitors (SSRIs).
Lexapro tablets and oral solution are used to treat:
Depression
Generalized Anxiety Disorder (GAD)
Who Should Not Take Lexapro?
Never take Lexapro if you are taking another drug used to treat depression called a Monoamine Oxidase Inhibitor (MAOI), or if you have stopped taking an MAOI in the last 14 days. Taking Lexapro close in time to an MAOI can result in serious, sometimes fatal, reactions, including:
High body temperature
Coma
Seizures (convulsions)
MAOI drugs include Nardil (phenelzine sulfate), Parnate (tranylcypromine sulfate). Marplan (isocarboxazid), and other brands.
Suicidal thoughts or actions: See FDA Alert.
Stopping Lexapro: Do not stop taking Lexapro suddenly because you could get side effects. Your healthcare professional will slowly decrease your dose.
Lexapro is taken by mouth, with or without food, exactly as prescribed by your healthcare professional.
This information is provided by the U.S. Food & Drug Administration.
For more information about this drug, click here.
Accupril
Actonel
Actos
Allegra
Altace
Atenolol
Avandia
Celebrex
Celexa
Cialis
Coreg
Cozaar
Crestor
Diovan
Effexor
Evista
Flomax
Fluoxetine
Fosamax
Glucophage
Latisse
Levitra
Levoxyl
Lexapro
Lipitor
Lisinopril
Metformin
Neurontin
Nexium
Norvasc
Paxil
Plavix
Pravachol
Premarin
Prevacid
Prilosec
Propecia
Protonix
Prozac
Seroquel
Simvastatin
Singulair
Toprol-XL
Viagra
Zetia
Zithromax
Zocor
Zoloft
Zyprexa
Zyrtec